Ph.D., Professor of Pathology Director, Clinical Genomics and Advanced Technology, Department of Pathology, Geisel School of Medicine, Dartmouth College
Dr. Tsongalis is a leading investigator in molecular oncology and clinical genomics and is a past former President of the Association of Molecular Pathology. Dr. Tsongalis’s research includes developing novel technologies and approaches for biomarker discovery and molecular pathology using NGS and other advanced technologies. Dr. Tsongalis’ clinical lab focuses on DNA and RNA testing for oncology, pharmacogenomics and genetic disease testing.
QC: Where the Rubber Meets the Road
While next generation sequencing is an appealing technology that can generate vast amounts of information using clinical samples, the quality control and assurance of accurate results is of utmost importance. How can we improve implementation of NGS into a clinical lab setting, from assay development through clinical testing?
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: As an enabling technology, next generation sequencing has made possible significant advances in precision medicine and genomic diagnostics. This session will focus on efforts to ensure that NGS test results achieve the highest accuracy possible. High quality genomic controls and reference materials and the technologies used to develop them will be discussed. Both industry and academic researcher perspectives will be represented.